SummaryOver 7,000 chikungunya cases in Foshan, China, have triggered strict COVID-era measures, including biological mosquito control, pharmacy surveillance, fines for non-compliance, and public disinfection drives. Authorities are using aggressive tactics, mirroring pandemic protocols, to curb the mosquito-borne virus, which causes fever and joint pain but lacks specific treatment or widely available vaccines.